The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Bernard Chevalier

Showing 1-20 of 37 articles
Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry
Mohamed M, Polad J, Hildick-Smith D, Bizeau O, Baisebenov R, Roffi M, Íñiguez-Romo A, Chevalier B, von Birgelen C, Roguin A, Aminian A, Angioi M, Mamas M
September 18, 2020 | 10.4244/EIJ-D-20-00361
Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry
Mohamed M, Polad J, Hildick-Smith D, Bizeau O, Baisebenov R, Roffi M, Íñiguez-Romo A, Chevalier B, von Birgelen C, Roguin A, Aminian A, Angioi M, Mamas M
June 25, 2020 | 10.4244/EIJ-D-20-00361
Coronary interventions
Bioresorbable scaffolds versus everolimus-eluting metallic stents: Five years clinical outcomes of the randomised ABSORB II trial
Onuma Y, Chevalier B, Ono M, Cequier A, Dudek D, Haude M, Carrié D, Sabate M, Windecker S, Rapoza R, West N, Reith S, de Sousa Almeida M, Campo G, Iñiguez A, Serruys P
June 9, 2020 | 10.4244/EIJ-D-20-00024
Coronary interventions
Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis: The COMPARE-ABSORB Randomized Clinical Trial
Smits P, Chang C, Chevalier B, West N, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Włodarczak A, Abdel-Wahab M, Esposito G, Tijssen J, Morice M, Onuma Y, van Geuns R
May 26, 2020 | 10.4244/EIJ-D-19-01079
Coronary interventions
Acute and long-term relocation of minimal lumen area after bioresorbable scaffold or metallic stent implantation
Katagiri Y, Serruys P, Tenekecioglu E, Asano T, Collet C, Miyazaki Y, Katsikis A, Piek J, Wykrzykowska J, Chevalier B, Mintz G, Stone G, Onuma Y
September 20, 2019 | 10.4244/EIJ-D-18-00422
Coronary interventions
Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
Katagiri Y, Onuma Y, Asano T, Chichareon P, Collet C, Miyazaki Y, Piek J, Wykrzykowska J, Abizaid A, Ormiston J, Chevalier B, Serruys P
October 12, 2018 | 10.4244/EIJ-D-18-00301
Polymer-free drug-coated stents: workhorse or “niche horse”?
Urban P, Chevalier B
September 20, 2018 | 10.4244/EIJV14I7A128
Stents and scaffolds
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)
Chevalier B, Cequier A, Dudek D, Haude M, Carrié D, Sabate M, Windecker S, Reith S, de Sousa Almeida M, Campo G, Iñiguez A, Onuma Y, Serruys P
January 19, 2018 | 10.4244/EIJ-D-17-00873
Coronary interventions
Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial?
Roy A, Chevalier B, Lefèvre T, Louvard Y, Segurado R, Sawaya F, Spaziano M, Neylon A, Serruys P, Dawkins K, Kappetein AP, Mohr F, Colombo A, Feldman T, Morice M
September 20, 2017 | 10.4244/EIJ-D-16-00991
Coronary interventions
Chronic total coronary occlusion treated by percutaneous coronary intervention: long-term outcome in patients with and without diabetes
Sanguineti F, Garot P, O’Connor S, Watanabe Y, Spaziano M, Lefèvre T, Hovasse T, Benamer H, Unterseeh T, Chevalier B, Morice M, Louvard Y
February 3, 2017 | 10.4244/EIJ-D-15-00278
Coronary interventions
Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial
Chevalier B, Onuma Y, Van Boven A, Piek J, Sabate M, Helqvist S, Baumbach A, Smits P, Kumar R, Wasungu L, Serruys P
October 20, 2016 | 10.4244/EIJY16M08_01
Interventions for valvular disease
Patient-specific image-based computer simulation for the prediction of valve morphology and calcium displacement after TAVI with the Medtronic CoreValve and the Edwards SAPIEN valve
Schultz C, Rodriguez-Olivares R, Bosmans J, Lefèvre T, De Santis G, Bruining N, Collas V, Dezutter T, Bosmans B, Rahhab Z, Faquir N, Watanabe Y, Segers P, Verhegghe B, Chevalier B, Van Mieghem N, De Beule M, Mortier P, de Jaegere P
January 20, 2016 | 10.4244/EIJV11I9A212
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data
Bourantas C, Serruys P, Nakatani S, Zhang Y-J, Farooq V, Diletti R, Ligthart J, Sheehy A, van Geuns R, McClean D, Chevalier B, Windecker S, Koolen J, Ormiston J, Whitbourn R, Rapoza R, Veldhof S, Onuma Y, Garcia-Garcia H
November 20, 2015 | 10.4244/EIJY14M10_06
Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial
Chevalier B, Wijns W, Silber S, Garcia E, Serra A, Paunovic D, Serruys P
September 22, 2015 | 10.4244/EIJY14M12_13
Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold
Costa Jr J, Abizaid A, Bartorelli A, Whitbourn R, van Geuns R, Chevalier B, Perin M, Seth A, Botelho R, Serruys P
June 19, 2015 | 10.4244/EIJY15M05_06
Coronary interventions
The future of BRS in bifurcations
Kraak R, Grundeken M.J, Onuma Y, Tu S, Wykrzykowska J, Chevalier B, Ormiston J, Serruys P
May 19, 2015 | 10.4244/EIJV11SVA45
The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled
Abizaid A, Costa Jr J, Bartorelli A, Whitbourn R, van Geuns R, Chevalier B, Patel T, Seth A, Stuteville M, Dorange C, Cheong W-F, Sudhir K, Serruys P
April 20, 2015 | 10.4244/EIJV10I12A243
Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial
Bourantas C, Farooq V, Zhang Y-J, Muramatsu T, Gogas B, Thuesen L, McClean D, Chevalier B, Windecker S, Koolen J, Ormiston J, Whitbourn R, Dorange C, Rapoza R, Onuma Y, Garcia-Garcia H, Serruys P
March 20, 2015 | 10.4244/EIJY14M04_11
Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months
Serruys P, Onuma Y, Garcia-Garcia H, Muramatsu T, van Geuns R, De Bruyne B, Dudek D, Thuesen L, Smits P, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert K, Rapoza R, Ormiston J
March 20, 2014 | 10.4244/EIJV9I11A217
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials
Gogas B, Bourantas C, Garcia-Garcia H, Onuma Y, Muramatsu T, Farooq V, Diletti R, van Geuns R, De Bruyne B, Chevalier B, Thuesen L, Smits P, Dudek D, Koolen J, Windecker S, Whitbourn R, McClean D, Dorange C, Miquel-Hebert K, Veldhof S, Rapoza R, Ormiston J, Serruys P
October 25, 2013 | 10.4244/EIJV9I6A115

Latest news

NEW ISSUE
Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…
Tetralogy of Fallot with acquired double right ventricular outflow tract
September 18, 2020
NEW
Device entrapment in chronic total occlusions
September 30, 2020
Editorial
Complex PCI: time for a universal definition
Joanna J. Wykrzykowska
September 30, 2020
JAA
This Week's JAA's: Impact of neoatherosclerosis in ISR on clinical outcome...
September 29, 2020
Spyral, Popular-Tavi, Sort out IX, Solve TAVI, and more
(Released thanks to the support of Biotronik)
September 30, 2020
Editorial
Integrating physiology in OCT
Gianluca Campo
September 23, 2020
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke